Viewing Study NCT01328106


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2026-04-22 @ 2:46 PM
Study NCT ID: NCT01328106
Status: WITHDRAWN
Last Update Posted: 2017-12-12
First Post: 2010-03-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None GNA11 Mutation-positive Metastatic Melanoma View
None GNAQ Mutation-positive Metastatic Melanoma View
None Cancer View
None Metastatic Uveal Melanoma View
Keywords: